Literature DB >> 18321759

Uric acid associates with cognition in Parkinson's disease.

Tua Annanmaki1, Anniina Pessala-Driver, Laura Hokkanen, Kari Murros.   

Abstract

Cognitive dysfunction is common in Parkinson's disease (PD). Low plasma uric acid level is a risk factor for PD but its association with cognitive impairment in PD has not been previously studied. In the present study urine uric acid level as well as plasma uric acid- and homocysteine levels were measured in 40 patients with PD. Comprehensive neuropsychological tests including computerized tasks were performed on all. Both low plasma and low urine uric acid levels associated with decreased neuropsychological performance. In multiple linear regression low urine uric acid level predicted worse performance in the Picture completion subtest of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) (p=0.003) and in the Rule shift cards test of the Behavioral Assessment of the Dysexecutive Syndrome (BADS) (p=0.04). Low plasma uric acid level predicted worse performance both in the Picture completion (p=0.02) and Similarities subtest of the WAIS-R (p=0.02). Reaction time and the time spent on cognitive processing in the Statement verification task were inversely correlated with the uric acid levels (p=0.0001). There was no correlation between the homocysteine level and neuropsychological performance. Instead, the plasma uric acid and homocysteine levels correlated significantly and their possible association in PD is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321759     DOI: 10.1016/j.parkreldis.2007.11.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  26 in total

Review 1.  Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Authors:  Alvaro Alonso; Kelly A Sovell
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

2.  Altered N100-potential associates with working memory impairment in Parkinson's disease.

Authors:  Tua Annanmaki; Kirsi Palmu; Kari Murros; Juhani Partanen
Journal:  J Neural Transm (Vienna)       Date:  2017-07-14       Impact factor: 3.575

Review 3.  What can biomarkers tell us about cognition in Parkinson's disease?

Authors:  Brit Mollenhauer; Lynn Rochester; Alice Chen-Plotkin; David Brooks
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 4.  The Role of Uric Acid and Methyl Derivatives in the Prevention of Age-Related Neurodegenerative Disorders.

Authors:  Roy G Cutler; Simonetta Camandola; Kelli F Malott; Maria A Edelhauser; Mark P Mattson
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

5.  Serum uric acid levels and freezing of gait in Parkinson's disease.

Authors:  Ruwei Ou; Bei Cao; Qianqian Wei; Yanbing Hou; Yaqian Xu; Wei Song; Bi Zhao; Huifang Shang
Journal:  Neurol Sci       Date:  2017-03-01       Impact factor: 3.307

6.  The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson's disease: preliminary observations.

Authors:  Branislav Veselý; Eva Koriťáková; Nicolaas I Bohnen; Daša Viszlayová; Silvia Királová; Peter Valkovič; Egon Kurča; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2019-07-22       Impact factor: 3.575

Review 7.  Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.

Authors:  Sara Cipriani; Xiqun Chen; Michael A Schwarzschild
Journal:  Biomark Med       Date:  2010-10       Impact factor: 2.851

8.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.

Authors:  Marina Picillo; Gabriella Santangelo; Marcello Moccia; Roberto Erro; Marianna Amboni; Elio Prestipino; Katia Longo; Carmine Vitale; Emanuele Spina; Giuseppe Orefice; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

Review 10.  Urate in Parkinson's disease: more than a biomarker?

Authors:  Xiqun Chen; Guanhui Wu; Michael A Schwarzschild
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.